{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:10:56Z","timestamp":1768781456771,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":418,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20194Y0169"],"award-info":[{"award-number":["20194Y0169"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["GWV-10.1-XK16"],"award-info":[{"award-number":["GWV-10.1-XK16"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872679"],"award-info":[{"award-number":["81872679"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.cmi.2022.10.002","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T13:11:07Z","timestamp":1665061867000},"page":"353-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatment"],"prefix":"10.1016","volume":"29","author":[{"given":"Yangyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenlei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xubin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2022.10.002_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1183\/09031936.00024008","article-title":"Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease","volume":"33","author":"Santin","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2022.10.002_bib2","doi-asserted-by":"crossref","first-page":"5.1.11","DOI":"10.1128\/microbiolspec.TNMI7-0024-2016","article-title":"Nontuberculous mycobacteria\u2014overview","volume":"5","author":"Koh","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cmi.2022.10.002_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2022.10.002_bib4","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3389\/fmicb.2019.02918","article-title":"Genomic insights into the Mycobacterium kansasii complex: an update","volume":"10","author":"Jagielski","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2022.10.002_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01528-20","article-title":"Current updates on mycobacterial taxonomy, 2018 to 2019","volume":"59","author":"Armstrong","year":"2021","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2022.10.002_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.cmi.2022.10.002_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00250-2019","article-title":"Non-tuberculous mycobacterial pulmonary disease","volume":"54","author":"Cowman","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2022.10.002_bib8","article-title":"Increase in nontuberculous mycobacteria isolated in Shanghai, China: results from a population-based study","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2022.10.002_bib9","first-page":"558","article-title":"The prevalence of non-tuberculous mycobacterial infections in mainland China: systematic review and meta-analysis","volume":"73","author":"Yu","year":"2016","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2022.10.002_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2022.10.002_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2017-210929","article-title":"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2022.10.002_bib12","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/clinids\/18.5.736","article-title":"Rifampin-resistant Mycobacterium kansasii","volume":"18","author":"Wallace","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2022.10.002_bib13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/dkp238","article-title":"Clinical manifestations, antibiotic susceptibility and molecular analysis of Mycobacterium kansasii isolates from a university hospital in Taiwan","volume":"64","author":"Wu","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2022.10.002_bib14","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3389\/fmicb.2016.02097","article-title":"Mycobacterium kansasii subtype I is associated with clarithromycin resistance in China","volume":"7","author":"Li","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2022.10.002_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jgar.2019.05.003","article-title":"Drug susceptibility profile of Mycobacterium kansasii clinical isolates from Brazil","volume":"19","author":"de Carvalho","year":"2019","journal-title":"J\u00a0Glob Antimicrob Resist"},{"key":"10.1016\/j.cmi.2022.10.002_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40249-021-00844-1","article-title":"Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey","volume":"10","author":"Liu","year":"2021","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.cmi.2022.10.002_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01475-21","article-title":"Clinical and microbiological characteristics of Mycobacterium kansasii pulmonary infections in China","volume":"10","author":"Guo","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cmi.2022.10.002_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01788-17","article-title":"Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium kansasii","volume":"62","author":"Baku\u0142a","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.10.002_bib19","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.3389\/fmicb.2018.02271","article-title":"Therapy for Mycobacterium kansasii infection: beyond 2018","volume":"9","author":"DeStefano","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2022.10.002_bib20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1126\/science.aaf8156","article-title":"Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium","volume":"354","author":"Bryant","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cmi.2022.10.002_bib21","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1038\/s41467-021-22760-6","article-title":"Population genomics provides insights into the evolution and adaptation to humans of the waterborne pathogen Mycobacterium kansasii","volume":"12","author":"Luo","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2022.10.002_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0038-1660473","article-title":"Treatment of other nontuberculous mycobacteria","volume":"39","author":"Basille","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2022.10.002_bib23","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/jac\/dki111","article-title":"In\u00a0vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii","volume":"55","author":"Guna","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2022.10.002_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13073-019-0650-x","article-title":"Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs","volume":"11","author":"Phelan","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.cmi.2022.10.002_bib25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cmi.2021.09.014","article-title":"Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China","volume":"28","author":"Liu","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2022.10.002_bib26","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1128\/AAC.42.8.2084","article-title":"Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria","volume":"42","author":"Guillemin","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.10.002_bib27","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1038\/emi.2014.21","article-title":"Association of gyrA\/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis","volume":"3","author":"Li","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.cmi.2022.10.002_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01925-2021","article-title":"Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China","volume":"59","author":"Zheng","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2022.10.002_bib29","first-page":"96","article-title":"Drug resistance in nontuberculous mycobacteria: mechanisms and models","volume":"10","author":"Saxena","year":"2021","journal-title":"Biology (Basel)"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22005158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X22005158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:34:43Z","timestamp":1761118483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X22005158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1198743X22005158"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2022.10.002","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatment","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2022.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}